These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 21894564)
21. Glutathione accumulation in ethanol-stat fed-batch culture of Saccharomyces cerevisiae with a switch to cysteine feeding. Nisamedtinov I; Kevvai K; Orumets K; Rautio JJ; Paalme T Appl Microbiol Biotechnol; 2010 Jun; 87(1):175-83. PubMed ID: 20217077 [TBL] [Abstract][Full Text] [Related]
22. TRAPP webserver: predicting protein binding site flexibility and detecting transient binding pockets. Stank A; Kokh DB; Horn M; Sizikova E; Neil R; Panecka J; Richter S; Wade RC Nucleic Acids Res; 2017 Jul; 45(W1):W325-W330. PubMed ID: 28431137 [TBL] [Abstract][Full Text] [Related]
23. Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity. González-Chávez Z; Vázquez C; Mejia-Tlachi M; Márquez-Dueñas C; Manning-Cela R; Encalada R; Rodríguez-Enríquez S; Michels PAM; Moreno-Sánchez R; Saavedra E Redox Biol; 2019 Sep; 26():101231. PubMed ID: 31203195 [TBL] [Abstract][Full Text] [Related]
29. Characterization of the M32 metallocarboxypeptidase of Trypanosoma brucei: differences and similarities with its orthologue in Trypanosoma cruzi. Frasch AP; Carmona AK; Juliano L; Cazzulo JJ; Niemirowicz GT Mol Biochem Parasitol; 2012 Aug; 184(2):63-70. PubMed ID: 22575602 [TBL] [Abstract][Full Text] [Related]
30. Structural modelling and comparative analysis of homologous, analogous and specific proteins from Trypanosoma cruzi versus Homo sapiens: putative drug targets for chagas' disease treatment. Capriles PV; Guimarães AC; Otto TD; Miranda AB; Dardenne LE; Degrave WM BMC Genomics; 2010 Oct; 11():610. PubMed ID: 21034488 [TBL] [Abstract][Full Text] [Related]
31. Studies of 4-arylthiazolylhydrazones derived from 1-indanones as Trypanosoma cruzi squalene epoxidase inhibitors by molecular simulations. Noguera GJ; Fabian LE; Lombardo E; Finkielsztein LM Org Biomol Chem; 2018 Nov; 16(44):8525-8536. PubMed ID: 30357228 [TBL] [Abstract][Full Text] [Related]
32. Key proteins in the polyamine-trypanothione pathway as drug targets against Trypanosoma cruzi. Maya JD; Salas CO; Aguilera-Venegas B; Diaz MV; López-Muñoz R Curr Med Chem; 2014; 21(15):1757-71. PubMed ID: 24251576 [TBL] [Abstract][Full Text] [Related]
33. Enzymatic defects underlying hereditary glutamate cysteine ligase deficiency are mitigated by association of the catalytic and regulatory subunits. Willis MN; Liu Y; Biterova EI; Simpson MA; Kim H; Lee J; Barycki JJ Biochemistry; 2011 Jul; 50(29):6508-17. PubMed ID: 21657237 [TBL] [Abstract][Full Text] [Related]
34. Cloning and functional expression of Rpn1, a regulatory-particle non-ATPase subunit 1, of proteasome from Trypanosoma cruzi. Zou CB; Nakajima-Shimada J; Nara T; Aoki T Mol Biochem Parasitol; 2000 Oct; 110(2):323-31. PubMed ID: 11071286 [TBL] [Abstract][Full Text] [Related]
35. Drug target validation of the trypanothione pathway enzymes through metabolic modelling. Olin-Sandoval V; González-Chávez Z; Berzunza-Cruz M; Martínez I; Jasso-Chávez R; Becker I; Espinoza B; Moreno-Sánchez R; Saavedra E FEBS J; 2012 May; 279(10):1811-33. PubMed ID: 22394478 [TBL] [Abstract][Full Text] [Related]
36. Probing the cruzain S2 recognition subsite: a kinetic and binding energy calculation study. Polticelli F; Zaini G; Bolli A; Antonini G; Gradoni L; Ascenzi P Biochemistry; 2005 Mar; 44(8):2781-9. PubMed ID: 15723522 [TBL] [Abstract][Full Text] [Related]
37. Synthesis, Biological Evaluation and Molecular Docking of New Benzenesulfonylhydrazone as Potential anti-Trypanosoma cruzi Agents. Elizondo-Jimenez S; Moreno-Herrera A; Reyes-Olivares R; Dorantes-Gonzalez E; Nogueda-Torres B; Oliveira EAG; Romeiro NC; Lima LM; Palos I; Rivera G Med Chem; 2017; 13(2):149-158. PubMed ID: 27396731 [TBL] [Abstract][Full Text] [Related]
38. Application of bioisosterism in design of the semicarbazone derivatives as cruzain inhibitors: a theoretical and experimental study. Vital DG; Damasceno FS; Rapado LN; Silber AM; Vilella FS; Ferreira RS; Maltarollo VG; Trossini GH J Biomol Struct Dyn; 2017 May; 35(6):1244-1259. PubMed ID: 27064715 [TBL] [Abstract][Full Text] [Related]
39. Structure-Based Virtual Screening and In Vitro Evaluation of New Herrera-Mayorga V; Lara-Ramírez EE; Chacón-Vargas KF; Aguirre-Alvarado C; Rodríguez-Páez L; Alcántara-Farfán V; Cordero-Martínez J; Nogueda-Torres B; Reyes-Espinosa F; Bocanegra-García V; Rivera G Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30970549 [TBL] [Abstract][Full Text] [Related]